Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Breast 2Thoracic 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1CNS 1

Conditions

Ovarian Neoplasms 810Uterine Cervical Neoplasms 545Endometrial Neoplasms 466Breast Neoplasms 223Fallopian Tube Neoplasms 202Colorectal Neoplasms 181Carcinoma, Non-Small-Cell Lung 163Neoplasms 139Stomach Neoplasms 128Pancreatic Neoplasms 119Prostatic Neoplasms 108Neoplasm Metastasis 107Melanoma 107Lung Neoplasms 104Carcinoma, Ovarian Epithelial 94Triple Negative Breast Neoplasms 91Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 78Head and Neck Neoplasms 76Urinary Bladder Neoplasms 75Carcinoma, Renal Cell 75Uterine Neoplasms 66Vulvar Neoplasms 65Uterine Cervical Dysplasia 59Peritoneal Neoplasms 59Colonic Neoplasms 59Carcinoma, Hepatocellular 58Sarcoma 53Carcinoma, Transitional Cell 48Papillomavirus Infections 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Gynecologic × 1 year × Clear all
NCT05721326 2026-01-13

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Abramson Cancer Center at Penn Medicine

Phase NA Completed
1,330 enrolled
BreastGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡